PT Kimia Farma (Persero) Tbk (KAEF):企業の財務・戦略的SWOT分析

◆英語タイトル:PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7723
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥51,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PT Kimia Farma (Persero) Tbk (KAEF) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular and hematopoietic, dermatological, eye and ear, genito – urinary system, hormones, intravenous and other sterile, metabolism, neuromuscular, other chemoterapetics, respiratory, vitamin and minerals and others. Kimia Farma distributes its products in various countries across the world including Asia, Europe and Africa. The company operates manufacturing plants in Jakarta, Bandung, Semarang, Watudakon, Medan and West Java. Kimia Farma is headquartered in Jakarta, Indonesia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
PT Kimia Farma (Persero) Tbk – Key Facts 6
PT Kimia Farma (Persero) Tbk – Key Employees 7
PT Kimia Farma (Persero) Tbk – Major Products and Services 8
PT Kimia Farma (Persero) Tbk – History 9
PT Kimia Farma (Persero) Tbk – Company Statement 11
PT Kimia Farma (Persero) Tbk – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 13
Section 2 – Company Analysis 14
Company Overview 14
PT Kimia Farma (Persero) Tbk – Business Description 15
Business Segment: Distribution Segment 15
Overview 15
Performance 15
Business Segment: Manufacturing Segment 15
Overview 15
Performance 15
Business Segment: Other Segment 16
Performance 16
Business Segment: Retail Segment 16
Overview 16
Performance 16
R&D Overview 16
PT Kimia Farma (Persero) Tbk – Corporate Strategy 17
PT Kimia Farma (Persero) Tbk – SWOT Analysis 18
SWOT Analysis – Overview 18
PT Kimia Farma (Persero) Tbk – Strengths 18
PT Kimia Farma (Persero) Tbk – Weaknesses 19
PT Kimia Farma (Persero) Tbk – Opportunities 20
PT Kimia Farma (Persero) Tbk – Threats 21
PT Kimia Farma (Persero) Tbk – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
PT Kimia Farma (Persero) Tbk, Recent Deals Summary 32
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
PT Kimia Farma (Persero) Tbk, Key Facts 6
PT Kimia Farma (Persero) Tbk, Key Employees 7
PT Kimia Farma (Persero) Tbk, Major Products and Services 8
PT Kimia Farma (Persero) Tbk, History 9
PT Kimia Farma (Persero) Tbk, Other Locations 12
PT Kimia Farma (Persero) Tbk, Subsidiaries 12
PT Kimia Farma (Persero) Tbk, Joint Venture 13
PT Kimia Farma (Persero) Tbk, Key Competitors 22
PT Kimia Farma (Persero) Tbk, Ratios based on current share price 23
PT Kimia Farma (Persero) Tbk, Annual Ratios 24
PT Kimia Farma (Persero) Tbk, Annual Ratios (Cont...1) 25
PT Kimia Farma (Persero) Tbk, Annual Ratios (Cont...2) 26
PT Kimia Farma (Persero) Tbk, Interim Ratios 28
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
PT Kimia Farma (Persero) Tbk, Recent Deals Summary 32
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
PT Kimia Farma (Persero) Tbk, Performance Chart (2013 - 2017) 27
PT Kimia Farma (Persero) Tbk, Ratio Charts 29
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

★海外企業調査レポート[PT Kimia Farma (Persero) Tbk (KAEF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Co-Diagnostics Inc (CODX):企業の製品パイプライン分析
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Bharat Petroleum Corp Ltd (BPCL):石油・ガス:M&Aディール及び事業提携情報
    Summary Bharat Petroleum Corp Ltd (BPCL) is an integrated oil and gas company. It carries out production of oil and natural gas; refining of crude oil; and marketing and distribution of petroleum products. The company also focuses on renewable energy. It produces oil products including light distill …
  • Union Electrica SA:企業の戦略的SWOT分析
    Union Electrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Genmab AS (GMAB):企業の財務・戦略的SWOT分析
    Genmab AS (GMAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Plethora Solutions Holdings Plc:製薬・医療:M&Aディール及び事業提携情報
    Summary Plethora Solutions Holdings plc (Plethora), a subsidiary of Regent Pacific is a pharmaceutical company which develops and markets products for the treatment and management of urological disorders. It focuses on the development of medicines for the treatment of urology and sexual health. The …
  • Sapura Energy Bhd (SENERGY):企業の財務・戦略的SWOT分析
    Sapura Energy Bhd (SENERGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MDU Resources Group Inc (MDU):企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Publix Super Markets, Inc.:企業の戦略・SWOT・財務分析
    Publix Super Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Publix Super Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • KFG Resources Ltd (KFG):企業の財務・戦略的SWOT分析
    Summary KFG Resources Ltd (KFG) is a petroleum and natural gas exploration company that supplies natural gas. The company produces crude oil and natural gas through its reserves. Its oil and gas reserves are located in Mississippi, Wilcox, and Louisiana. KFG’s Mississippi’s projects comprise Carthag …
  • China National Offshore Oil Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Offshore Oil Corp (CNOOC) carries out exploration, development, and production of crude oil and natural gas. The company also offers engineering and technical services, including oilfield, offshore oil engineering, and professional services. It is also involved in the producti …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Daniel Thwaites Plc:戦略・SWOT・企業財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Iroko Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Iroko Pharmaceuticals LLC (Iroko) is a pharmaceutical company that develops treatment options for responsible pain management. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of nonclinic …
  • Peakdale Molecular Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Peakdale Molecular Ltd (Peakdale), a subsidiary of Concept Life Sciences Ltd, is a company that offers drug discovery services. It service portfolio offers services including drug discovery, nucleoside chemistry, materials chemistry and research support services. Peakdale offers research sup …
  • Ascena Retail Group, Inc.:企業の戦略・SWOT・財務分析
    Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Matrix Service Co:企業の戦略・SWOT・財務分析
    Matrix Service Co - Strategy, SWOT and Corporate Finance Report Summary Matrix Service Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆